2011
DOI: 10.1016/j.steroids.2010.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Long-term hormonal promotion overcomes genetic resistance to mammary cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…Pregnancy also decreases the number of mammary stem cells [85, 86]. However, the protective pathways activated during pregnancy can be eroded by prolonged exposure to exogenous 17β-estradiol which restores sensitivity to carcinogen-induced mammary tumors [8789]. These observations may explain why pregnancy is accompanied by a short-term increase in breast cancer risk [12, 90]; “pregnancy-associated breast cancer” has poorer overall survival [91, 92].…”
Section: Introductionmentioning
confidence: 99%
“…Pregnancy also decreases the number of mammary stem cells [85, 86]. However, the protective pathways activated during pregnancy can be eroded by prolonged exposure to exogenous 17β-estradiol which restores sensitivity to carcinogen-induced mammary tumors [8789]. These observations may explain why pregnancy is accompanied by a short-term increase in breast cancer risk [12, 90]; “pregnancy-associated breast cancer” has poorer overall survival [91, 92].…”
Section: Introductionmentioning
confidence: 99%
“…We have demonstrated that short-term treatment with estrogen or estrogen plus progesterone is effective in reducing breast cancer risk in rodent models [38][39][40]. We have also shown that long-term treatment with the same steroids increases the risk of breast cancer [41][42][43]. In conclusion, the evidence on duration of hormone treatment and the associated risk of breast cancer is controversial, with most of the data indicating that shorter treatment durations lead to decreased risk of breast cancer.…”
Section: Duration Of Hormone Therapy and Breast Cancer Riskmentioning
confidence: 85%
“…It is also possible that systemic factors affect tumor development. Long-term hormone administration to COP rats has been reported to promote development of mammary tumors that would otherwise undergo spontaneous regression [44]. Fat tissue is a source of estrogen, especially after senescence of ovarian function; thus, obesity and being overweight promote breast cancer development [45].…”
Section: Plos Onementioning
confidence: 99%